Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
ETFs with exposure to Arcutis Biotherapeutics, Inc. (ARQT)
Virtus LifeSci Biotech Products ETF - USD This ETF provides exposure to Equally Weighted US Equities | 6.96% | +19.00% | +24.27% | +€82K | +€26M | €78M | 0.34% | |
|---|---|---|---|---|---|---|---|---|
1.12% | +3.35% | +10.82% | €0 | -€542K | €55M | 0.75% | ||
Samsung KODEX SYNTH-US Biotech ETF - KRW This ETF provides exposure to Equally Weighted US Biotechnology Equities | 0.99% | +20.20% | +35.88% | €0 | -€69K | €15M | 0.25% | Not rated |
Global X S&P Biotech ETF - AUD This ETF provides exposure to Equally Weighted US Biotechnology Equities | 0.99% | +27.36% | +26.43% | +€924K | +€212K | €32M | 0.45% | Not rated |
State Street SPDR S&P Biotech ETF - USD This ETF provides exposure to Equally Weighted US Biotechnology Equities | 0.98% | +25.77% | +31.73% | +€881M | +€532M | €9.56B | 0.35% | |
First Trust Nasdaq Pharmaceuticals ETF - USD This ETF provides exposure to Other US Pharmaceuticals Equities | 0.41% | +13.64% | +19.37% | -€1.5M | +€8.8M | €33M | 0.6% | |
0.39% | +19.56% | +13.03% | +€1.7M | +€3.3M | €25M | 0.5% | Not rated | |
First Trust Small Cap Growth AlphaDEX Fund ETF - USD This ETF provides exposure to Other Small Cap US Equities | 0.29% | +7.22% | +28.64% | +€47M | +€233M | €1.12B | 0.7% | |
Amplify Etho Climate Leadership U.S. ETF - USD This ETF provides exposure to Equally Weighted US Equities | 0.27% | +3.13% | +21.99% | €0 | -€30K | €164M | 0.45% | |
iShares Nasdaq US Biotechnology UCITS ETF (D) - USD This ETF provides exposure to US Equities Share class Dist USD | 0.21% | +18.64% | +18.65% | +€500K | +€947K | €55M | 0.35% | |
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
